A Phase 1 Study to Assess Safety and Tolerability of Amicidin-β Topical Solution in Adult Patients Undergoing Interventional Management of a Contaminated or Infected Surgical or Traumatic Wound or Cutaneous Abscess
Macro Biologics, Inc.
Summary
The goal of this Phase 1 clinical trial is to learn about the safety profile of Amicidin-β topical solution applied directly into contaminated or infected surgical or traumatic wounds or cutaneous abscess during a surgical procedure. The main questions it aims to answer are: 1. Is Amicidin-β topical solution safe to test in larger clinical trials? 2. Is Amicidin-β topical solution absorbed into the bloodstream from local wound application? 3. Is Amicidin-β topical solution easy for the surgeon to use? Participants will receive either standard of care alone, or standard of care with intrawound Amicidin-β topical solution for the management of their wound infection. Researchers will compare these two groups (standard of care alone to standard of care with Amicidin-β topical solution) to see if there are any study drug-related adverse effects.
Description
This is a Standard of Care (SOC)- controlled study of approximately 44 patients divided into three sequential cohorts of 8, 12, and 24 patients. Within each sequential cohort, patients will be randomized to SOC only or to SOC plus Amicidin-β topical solution in a 1:3 ratio.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Main Inclusion Criteria: * Surgical or traumatic wound ≤90 days old or a cutaneous abscess that is: 1. ≥3 cm in length of longest dimension; 2. requires an interventional procedure, such as opening, incision, drainage, irrigation, and/or debridement; and 3. is anticipated by the Investigator to be Class III (contaminated) or Class IV (dirty/infected). * If female of childbearing potential, must have been practicing an acceptable method of birth control as judged by the Investigator for at least one month prior to enrollment. * Females of childbearing potential must agree that for the e…
Interventions
- DrugAmicidin-β topical solution - 15 mL
Amicidin-β topical solution for local administration - 15 mL
- DrugAmicidin-β topical solution - 50 mL
Amicidin-β topical solution for local administration - 50 mL
- DrugStandard of Care (SOC)
Per institutional Standard Of Care
Locations (5)
- Lundquist InstituteTorrance, California
- Snake River Research, PLLCIdaho Falls, Idaho
- LifeBridge HealthBaltimore, Maryland
- Washington University in St. LouisSt Louis, Missouri
- The Ohio State UniversityColumbus, Ohio